Kargbo Robert B
Usona Institute, Fitchburg, Wisconsin 53711-5300, United States.
ACS Med Chem Lett. 2024 Jul 25;15(8):1193-1195. doi: 10.1021/acsmedchemlett.4c00327. eCollection 2024 Aug 8.
The inhibition of phosphoinositide 3-kinases (PI3Ks) is a promising approach in cancer therapy due to their critical role in cellular growth, proliferation, and survival. This Patent Highlight explores the mechanism of action of novel PI3K inhibitors, emphasizing their efficacy in targeting various PI3K isoforms. The work integrates neuroprotective and anti-inflammatory strategies from related patents, highlighting their potential to enhance the therapeutic profile of these inhibitors. It also considers advanced diagnostic methods for monitoring treatment efficacy and safety, underscoring the need for a comprehensive approach to cancer treatment.
抑制磷酸肌醇3-激酶（PI3Ks）是癌症治疗中一种很有前景的方法，因为它们在细胞生长、增殖和存活中起着关键作用。本专利亮点探讨了新型PI3K抑制剂的作用机制，强调了它们在靶向各种PI3K亚型方面的功效。该研究整合了相关专利中的神经保护和抗炎策略，突出了它们增强这些抑制剂治疗效果的潜力。它还考虑了用于监测治疗效果和安全性的先进诊断方法，强调了癌症治疗需要综合方法。
